financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Shares Of Inspire Medical Systems, Inc.
Jun 11, 2024 8:46 AM

11:15 AM EDT, 06/11/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We cut our 12-month price target to $175 from $225 due to recent market movements, based on a forward P/E of 233x our 2025 EPS estimate of $0.75, a discount to INSP's historical forward average due to decelerating growth versus historical. We maintain our adjusted EPS estimate of $0.15 for 2024 and $0.75 for 2025. We still view the balance sheet favorably with good liquidity (i.e., a high current ratio of 7.9x) and solvency (i.e., total debt/capital low at just 4%). We see the company adding new centers ahead of its targets, which should bring additional top-line growth over the next one to two years. We also anticipate growth from the next-generation Inspire V soft launch later this year and the full launch next year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Adss Of Tencent Music Entertainment Group
Research Alert: CFRA Maintains Buy Opinion On Adss Of Tencent Music Entertainment Group
Mar 19, 2024
02:10 AM EDT, 03/20/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Following TME's in-line 2023 results, we keep our 2024 earnings per ADS forecast unchanged at CNY3.60, and we start 2025's at CNY4.36. Our 12-month target price is raised to USD13...
Research Alert: CFRA Maintains Strong Buy Opinion On Adrs Of Siemens
Research Alert: CFRA Maintains Strong Buy Opinion On Adrs Of Siemens
Mar 19, 2024
12:35 AM EDT, 03/20/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our target price at US$103 based on forward EV/EBITDA of 11.6x. This is at 0.25 standard deviation (SD) below 3-year average EV/EBITDA to reflect potential negative newsflow from...
Research Alert: CFRA Lowers Opinion On Shares Of Organon & Co To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Organon & Co To Hold From Buy
Mar 19, 2024
12:45 PM EDT, 03/19/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We reduce our 12-month target price to $19 from $22, 4.1x our 2025 EPS estimate. We lower our 2024 EPS estimate by $0.30 to $4.21 and our 2025 EPS view...
Stock Market Today: Stocks Close Higher After Nvidia's Reversal
Stock Market Today: Stocks Close Higher After Nvidia's Reversal
Mar 19, 2024
It was a slow start for stocks Tuesday as investors took in a historic move by Japan's central bank and looked ahead to tomorrow's policy announcement from the Federal Reserve. However, a midday reversal from mega-cap chipmaker Nvidia ( NVDA ) helped boost sentiment into the close.   It's a busy week for global central bank headlines. While tomorrow's statement...
Copyright 2023-2026 - www.financetom.com All Rights Reserved